Skip to main content
HomeDrug Comparisons
Drug bottle and Pill

Compare Novolog vs. Afrezza

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

NovoLog (insulin aspart) and Afrezza (insulin human inhaled) are both fast-acting insulins used to manage blood sugar levels in people with diabetes. NovoLog is injected under the skin or given as an infusion, while Afrezza is inhaled through the mouth. NovoLog can be used by both adults and children, whereas Afrezza is only approved for adults. Afrezza is a good option if you prefer not to use injections, but it cannot be used if you have breathing problems like asthma or chronic obstructive pulmonary disease (COPD). NovoLog starts working within 15 minutes and lasts for about 2 to 4 hours, while Afrezza starts working in about 12 minutes and lasts for 1.5 to 3 hours. Both medications can cause low blood sugar, but Afrezza also commonly causes cough and throat irritation. If you smoke or have recently quit, Afrezza is not recommended due to safety concerns.

  • Novolog (insulin aspart)
    Afrezza (insulin)
  • Novolog (insulin aspart)
    Afrezza (insulin)

  • Summary of Novolog vs. Afrezza

    Summary for Insulin
    Prescription only

    NovoLog (insulin aspart) is a fast-acting insulin for adults and children with diabetes. It lowers your blood sugar levels by moving the sugar into your body so it can be used for energy. NovoLog (insulin aspart) is available as vials and ready-to-use prefilled pens. It's typically injected under the skin at mealtimes, but it can also be given as an infusion into the veins by a healthcare provider for people in the hospital. Side effects include headache and low blood sugar (hypoglycemia).

    Summary for Insulin
    Prescription only

    Afrezza is an ultra rapid-acting inhaled insulin for adults with diabetes. It helps manage blood sugar levels from meals. You breathe in the medication through the mouth using the Afrezza inhaler usually at the start of meals. Common side effects are low blood sugar and cough. There's also a risk of bronchospasm (sudden narrowing of the airways), which can make it hard to breathe. So Afrezza (insulin) isn't for people with breathing problems like asthma or chronic obstructive pulmonary disease (COPD).

  • Indications of Novolog vs. Afrezza

    Indications for
    •Type 1 diabetes in adults and children
    •Type 2 diabetes in adults
    Indications for
    •Type 1 diabetes (T1D) in adults
    •Type 2 diabetes (T2D) in adults

  • Pros and Cons of Novolog vs. Afrezza

    Pros and Const for Insulin
    Pros
    •Starts to work within 10 minutes to lower blood sugar levels
    •Dose can be easily adjusted to make treatment tailored to your specific needs
    •Can use if you have liver or kidney problems
    •Available as a prefilled pen for easier and convenient use
    Cons
    •Given multiple times per day (before each meal)
    •Must give as an injection
    •Might be hard for some people to inject properly
    •Risk of low blood sugar and weight gain
    Pros and Const for Insulin
    Pros
    •A good choice for people who don't want to use injectable insulin
    •Can help people with either Type 1 or Type 2 diabetes manage blood sugar
    •Starts to work in about 12 minutes and lasts between 1.5 and 3 hours, depending on your dose
    Cons
    •Might need to use more than one cartridge of insulin for your dose (if you need more than 12 units of insulin)
    •Not for people who smoke or for people with breathing problems (e.g., asthma, COPD)
    •Not approved for children

  • Common Side Effects of Novolog vs. Afrezza

    Common Side Effects for

    Type 1 diabetes:

    •Severely low blood sugar (17%)
    •Headache (12%)
    •Accidental injury (11%)
    •Nausea (7%)
    •Diarrhea (5%)

    Type 2 diabetes:

    •Muscles slow to react (11%)
    •Severely low blood sugar (10%)
    •Fungal nail infection (10%)
    •Impairment of your senses (9%)
    •Urinary tract infection (8%)
    •Sinus infection (5%)
    •Chest pain (5%)
    •Stomach pain (5%)
    •Headache (5%)
    •Skin problems (5%)
    Common Side Effects for
    •Low blood sugar (up to 67%)
    •Cough (up to 29%)
    •Throat pain or irritation (up to 6%)
    •Headache (up to 5%)

  • Warnings of Novolog vs. Afrezza

    Common Side Effects for
    •Spread of infections from sharing injection supplies
    •Low blood sugar (hypoglycemia)
    •Low blood potassium levels
    •Swelling from fluid buildup and risk of heart failure when taken with certain blood sugar medications
    •Dangerously high blood sugar levels or buildup of ketones (for people who use insulin pump)
    Common Side Effects for
    •Breathing problems
    •Low blood sugar levels (hypoglycemia)
    •Changes in blood sugar levels with changes to your insulin routine
    •Diabetic ketoacidosis
    •Low potassium levels
    •Swelling from fluid buildup and risk of heart failure when taken with certain diabetes medications

  • Prices with our coupons for Novolog vs. Afrezza

    Learn more about Novolog
    Learn more about Afrezza

Compare other Diabetes Type 2 and Diabetes Type 1 drugs

Fiasp vs NovologGlucovance vs NovologLantus vs NovologLevemir vs NovologMetaglip vs NovologNovolog vs ActosNovolog vs AfrezzaNovolog vs ApidraNovolog vs OzempicPrecose vs NovologToujeo vs NovologGlucotrol vs GlucovanceGlucovance vs GlyburideGlucovance vs GlyxambiGlucovance vs HumalogGlucovance vs Human InsulinGlucovance vs JardianceGlucovance vs LantusGlucovance vs LevemirGlucovance vs OnglyzaInvokamet vs GlucovanceInvokana vs GlucovanceJanuvia vs GlucovanceLantus vs LevemirLevemir vs ActosLevemir vs ApidraLevemir vs BasaglarLevemir vs HumalogMetformin vs GlucovancePrecose vs Glucovance
View More

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.